Jump Financial »

Rapt Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $333k 9.8k 33.87

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics